Remedium Lifecare Ltd
₹ 108
-0.14%
26 Apr
4:01 p.m.
About
Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products
Key Points
- Market Cap ₹ 1,087 Cr.
- Current Price ₹ 108
- High / Low ₹ 180 / 53.5
- Stock P/E 20.6
- Book Value ₹ 2.19
- Dividend Yield 0.00 %
- ROCE 103 %
- ROE 71.0 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 252% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.6%
Cons
- Stock is trading at 49.1 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 1.11%
- Debtor days have increased from 88.6 to 123 days.
- Promoter holding has decreased over last 3 years: -33.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 2 | 4 | 1 | 0 | 0 | 3 | 90 | 505 | 510 | 2,709 | |
1 | 1 | 2 | 4 | 1 | 0 | 0 | 2 | 89 | 503 | 502 | 2,643 | |
Operating Profit | 0 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 1 | 2 | 8 | 65 |
OPM % | 7% | 3% | -8% | -8% | -7% | 0% | -44% | 14% | 1% | 0% | 2% | 2% |
0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 7 | 84 |
Tax % | 0% | 50% | 21% | 0% | 0% | 0% | 100% | 24% | 26% | 29% | 27% | |
0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 53 | |
EPS in Rs | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.11 | 0.54 | 5.25 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 329% |
3 Years: | 461% |
TTM: | 471% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 252% |
3 Years: | 169% |
TTM: | 400% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 188% |
3 Years: | 297% |
1 Year: | 102% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 45% |
Last Year: | 71% |
Balance Sheet
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 10 |
Reserves | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -0 | 0 | 1 | 7 | 12 |
1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 1 | |
2 | 1 | 3 | 2 | 0 | 0 | 0 | 1 | 24 | 219 | 1,144 | 1,883 | |
Total Liabilities | 6 | 6 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 1,154 | 1,906 |
2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | 4 | 4 | 5 | 3 | 3 | 4 | 4 | 38 | 224 | 1,154 | 1,906 | |
Total Assets | 6 | 6 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 1,154 | 1,906 |
Cash Flows
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | -1 | 0 | -0 | -0 | -0 | -10 | 11 | 20 | |||
0 | 1 | 0 | 0 | 1 | -0 | -0 | -0 | -0 | |||
-0 | -0 | 0 | 0 | 0 | 0 | 10 | -11 | -0 | |||
Net Cash Flow | -0 | 0 | 0 | -0 | 1 | -0 | -0 | 1 | 20 |
Ratios
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 203 | 120 | 341 | 265 | 596 | 2,117 | 319 | 189 | 96 | 46 | 123 |
Inventory Days | 1,506 | 1,129 | 243 | 78 | 0 | 0 | 5 | ||||
Days Payable | 162 | 102 | 438 | 129 | 62 | ||||||
Cash Conversion Cycle | 1,547 | 1,147 | 146 | 214 | 596 | 2,117 | 319 | 189 | 96 | 46 | 67 |
Working Capital Days | 607 | 566 | 107 | 200 | 524 | 2,159 | 4,745 | 323 | 54 | 2 | -8 |
ROCE % | 1% | 1% | 0% | 1% | 1% | 11% | 7% | 18% | 103% |
Documents
Announcements
- Compliance Certificate Under Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015 19 Apr
- Appoint Of Internal Auditor And Secretarial Auditor 12 Apr
-
Announcement under Regulation 30 (LODR)-Cessation
12 Apr - Listing Obligation and Disclosure Requirement) Regulations, 2015, cessation of Dr. Maneesha Naresh, current term of office is completed and she would not be able to …
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - In Compliance with Regulation 74(5) of the SEBI (DP) Regulations, 2018 , please find enclosed herewith copy of certificate received from Skyline Financial Services Private …
- Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirement), 2015 6 Apr
Business Overview:[1]
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets